Post by PharmaShots

Halozyme, Inc. entered a global collaboration and license agreement with GSK to develop SC oncology therapies, including ADCs, using Enhanze drug delivery technology, expanding its application across multiple cancer targets Subscribe to our weekly newsletter and never miss a beat: https://lnkd.in/gTU62Zbz #gsk #halozyme #oncology #collaboration #licensingdeal #adc #enhanze #pharma https://lnkd.in/gddDtHQ6